P14.61 Tumor Treating Fields (TTFields) combined with lomustine (CCNU) and temozolomide (TMZ) in newly diagnosed glioblastoma (GBM) patients - a bi-centric analysis

BACKGROUND: TTFields combined with TMZ demonstrated significantly improved PFS, OS and long-term survival in newly diagnosed glioblastoma (ndGBM) patients, compared to TMZ monotherapy in the EF-14 trial; independent of MGMT-promotor methylation-status, age, grade of resection and performance status....

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Main Authors: Lazaridis, L, Schäfer, N, Schmidt, T, Stoppek, A, Weller, J, Tzaridis, T, Scheffler, B, Pierscianek, D, Kleinschnitz, C, Stuschke, M, Sure, U, Herrlinger, U, Kebir, S, Glas, M
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2019
Assuntos:
Poster Presentations
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6795958/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz126.296
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares